Cochlear Implant Telemetry Patents: Who Leads, Where Gaps Are 2026
A data-backed view of the cochlear implant wireless telemetry patent landscape: filing trends, technology composition, leading assignees and white space, drawn from 506 records published 2015-2026.
Filing growth = 2021 (22 records) → 2024 (8); 2024 is the last year we treat as complete. Top-5 share = the 5 largest assignees ÷ all 506 records in scope (CR5), not the ranked leaders only.
What this landscape covers
Cochlear implant wireless telemetry sits at the intersection of implantable stimulation hardware and short-range data transfer: a coil or RF link that reports electrode status, battery state or signal strength back to an external processor, and that carries programming data forward into the implant. The scope here pulls records tagged against A61B, A61M, A61N, H04W and H04L where the text ties cochlear implants to telemetry, wireless transceivers or wireless data transmission, covering 506 records published between 2015 and the 2026 data cut-off.
Because publication trails filing by roughly 18 months, the most recent one to two years in any trend understate real activity; the dataset is best read through 2024 as the last complete year. Family counts, rather than raw document counts, are used for the assignee ranking so that continuation and multi-jurisdiction filing by the same applicant do not inflate its position.
Let an AI agent run this analysis on your own technology
Pick a task. Every answer cites the patents behind it.
Filing trend and technology composition
Two views of the same 506 records: how filing activity has moved year over year, and which IPC subclasses the underlying technology actually sits in.
A sharp rise, then a pullback from a 2021 peak
Annual filings rose to a peak of 22 in 2021 and had fallen to 8 by 2024, a -64% move over that span. 2017 opened the tracked window at 8. Because 2025 and 2026 are still being published, treat the apparent decline in the newest years as an artefact of lag rather than a confirmed slowdown.
Publication lags filing by roughly 18 months, so 2025 onwards are still filling in. Growth rates on this page therefore end at 2024; running them to the last bar would understate the field.
Electrotherapy dominates; audio, surgery and power sit well below it
A61N (electrotherapy and radiation therapy) appears on 95.5% of the 506 records, confirming that nearly every filing in scope touches implant stimulation itself. H04R (loudspeakers and audio transducers) follows at 34.2%, and A61B (diagnosis and surgery) and A61F (implants and prostheses) sit at 18.2% and 16.6%. Power-related classes H01M and H02J, and data-processing class G06F, each stay under 9%, well below the stimulation and audio classes that anchor the field.
Shares are the percentage of the 506 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.
Go deeper on Cochlear Implant Wireless Telemetry Patent Landscape with Eureka
This page is one run against one query. Ask Eureka your own question about cochlear implant wireless telemetry patent landscape and every answer comes back with the patent numbers behind it.
Try EurekaA representative filing and the most-cited prior art
Systems and methods for facilitating optimal alignment of cochlear implant system components
The filing describes a cochlear implant system that generates a wireless back telemetry signal during electrode lead insertion, an external headpiece that detects that signal, and a sound processor that converts detected signal strength into a Received Signal Strength Indicator so a clinician can present alignment quality during the procedure.Filed by Advanced Bionics AG, published 2020-07-09 as US20200215328A1.
| # | Publication no. | Patent title | Citations |
|---|---|---|---|
| 1 | US6308101B1 | Fully implantable cochlear implant system | 629 |
| 2 | US5571148A | Implantable multichannel stimulator | 579 |
| 3 | US6443891B1 | Telemetry modulation protocol system for medical devices | 512 |
| 4 | US5876425A | Power control loop for implantable tissue stimulator | 507 |
| 5 | US7337010B2 | Medical device having lithium-ion battery | 471 |
| 6 | US5603726A | Multichannel cochlear implant system including wearable speech processor | 447 |
| 7 | US20050182389A1 | Implantable medical device and patch system and method of use | 429 |
| 8 | US5814095A | Implantable microphone and implantable hearing aids utilizing same | 414 |
| 9 | US6205360B1 | Apparatus and method for automatically determining stimulation parameters | 401 |
| 10 | US6073050A | Efficient integrated RF telemetry transmitter for use with implantable device | 338 |
Citation counts favour older documents simply by virtue of longer exposure in the corpus; read them as markers of foundational influence, not current commercial weight.
Each row carries its publication number; clicking a row searches Eureka by that number.
Put your own technology through the same analysis
Eureka on the web
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →MCP server & REST API
When it has to run inside your own pipeline.
Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.
Browse MCP servers →What the numbers mean for a filing decision
Three findings that change how a freedom-to-operate or whitespace search in this field should be scoped.
The field is a five-company game
Five assignees account for 81.0% of all 506 records in scope, and the top 10 combined reach 90.1%. A newcomer is not entering a fragmented field; it is filing against a small set of incumbents who already occupy most of the claim space around telemetry-linked stimulation.
Activity has cooled from its 2021 peak
Filings rose to 22 in 2021 and fell to 8 by 2024, a -64% move. That decline predates the publication lag window, so it reflects a real pullback in filing volume rather than a reporting artefact, even though 2025-2026 figures are still incomplete.
Power management is comparatively under-claimed
A61N electrotherapy classification touches almost every record, but power-supply class H02J sits at only 5.7% and battery class H01M at 8.3%. Given how central power budgeting is to implant longevity, this gap is worth checking before assuming it is saturated.
Co-filing is thin and concentrated on one applicant
Only 10 co-assignee pairs appear across the dataset, and the strongest links all involve the same corporate applicant paired with different named inventors. Collaboration between separate corporate entities is rare in this space; most development stays in-house.
Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to cochlear implant wireless telemetry patent landscape, with the prior art for and against each one.
Where to take this analysis
The dataset points to specific next questions rather than a single conclusion.
Map the incumbent's claim boundaries
With five assignees holding 81.0% of records, a freedom-to-operate check should start by pulling full claim sets from the leaders before drafting anything in the telemetry-and-stimulation core.
Explore assignee claims in EurekaTest the power-management gap
H01M and H02J classes sit under 9% of records despite power budgeting being central to implant life; a scoped prior-art search here could surface real white space.
Run a whitespace search in EurekaWatch the lag-affected years
2025-2026 filing counts will keep rising as publications catch up; re-pull the trend in six to twelve months before drawing conclusions about a slowdown.
Track filing trends in EurekaCommon questions on this landscape
The assignee ranking covers 82 companies, and the leader alone accounts for 101 of the 506 records in scope, well ahead of fifth place at 33. The top five combined hold 81.0% of all records, and the top ten reach 90.1%, so activity is heavily concentrated rather than spread evenly across the ranked list. Anyone assessing this space should treat the leading few assignees as the primary reference point for freedom-to-operate work, since the remaining 77-plus companies each hold a comparatively small share.
Filing activity rose from 8 records in 2017 to a peak of 22 in 2021, then fell to 8 by 2024, a -64% decline over that three-year span. Because publication typically lags filing by around 18 months, the 2025 and 2026 figures in any pull of this data are still incomplete and should not be read as confirming a continued slide. Based on the complete years through 2024, however, the pullback from the 2021 peak is real.
A61N, the electrotherapy and radiation therapy classification, appears on 95.5% of the 506 records in scope, confirming that nearly every filing touches implant stimulation directly. H04R, covering loudspeakers and audio transducers, follows at 34.2%, reflecting the audio-processing side of these systems. Power-related classes such as H01M and H02J each sit under 9%, notably lower than the stimulation and audio classes, which suggests less claim density around battery and power-supply aspects specifically.
US20200215328A1, filed by Advanced Bionics AG and published 2020-07-09, describes a cochlear implant system that generates a wireless back telemetry signal during electrode lead insertion and an external headpiece that converts the detected signal strength into a Received Signal Strength Indicator for use during the surgical procedure. Its scope centres on using telemetry signal strength specifically to guide component alignment at implantation, rather than telemetry for general data transfer after implantation. Anyone designing an alignment-feedback feature during insertion should review its full claim set closely before finalising a similar approach.
Very concentrated at the top: five assignees hold 81.0% of the 506 records in scope, and the top ten hold 90.1%. Co-filing activity is also thin, with only 10 co-assignee pairs identified across the entire dataset, and the strongest of those pairs all link back to the same leading corporate applicant paired with different named inventors rather than to genuine cross-company collaboration. A new entrant should expect to compete against a small number of well-established portfolios rather than a fragmented field of many small players.
Research Cochlear Implant Wireless Telemetry Patent Landscape in depth with Eureka
Go past this page: query the whole cochlear implant wireless telemetry patent landscape corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.
Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.
Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.
Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company’s registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.